May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Retinal Thickness Mapping in Exudative Age–related Macular Degeneration.
Author Affiliations & Notes
  • A. Shakoor
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, IL
  • R. Zelkha
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, IL
  • N.P. Blair
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, IL
  • J.P. Gieser
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, IL
  • M. Shahidi
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, IL
  • Footnotes
    Commercial Relationships  A. Shakoor, None; R. Zelkha, None; N.P. Blair, None; J.P. Gieser, None; M. Shahidi, None.
  • Footnotes
    Support  NIH grant EY10314; VA
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2411. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Shakoor, R. Zelkha, N.P. Blair, J.P. Gieser, M. Shahidi; Retinal Thickness Mapping in Exudative Age–related Macular Degeneration. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2411.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate retinal thickness differences between areas with and without leakage on fluorescein angiography in patients with exudative age–related macular degeneration (AMD). Methods: An optical imaging system based on the retinal thickness analyzer (RTA) was used to generate optical section images that encompassed a 6 by 6 mm retinal area. Imaging was performed in one eye of nine patients (mean age, 71 + 6 years) with clinical diagnosis of AMD and choroidal neovascularization (CNV). Patients had either never undergone photodynamic therapy (PDT) (untreated) or had received one or more PDT treatments (treated). The digital optical section images were analyzed to map the retinal thickness with a spatial resolution of 200 microns. In each eye, the retinal thickness map was overlaid on a late phase fluorescein angiogram and six 400 by 400 micron areas were selected. Three areas had distinct leakage and the other three areas were without leakage based on angiograms. These areas were paired so that they would have had comparable thickness in healthy eyes. An average retinal thickness was obtained in areas with and without leakage in each eye. The retinal thickness measurements were compared statistically using Student’s t–Test. Results: A statistically significant difference in retinal thickness was found between areas with leakage (312 + 57 microns) and areas without leakage (276 + 26 microns) on angiography (P = 0.04). In untreated patients, areas with leakage (345 + 50 microns) were thicker than areas without leakage (283 + 19 microns) (P = 0.03). The mean difference in retinal thickness between the 2 areas was 62 + 43 microns. In treated patients, the retinal thickness in areas with and without leakage was similar. The mean retinal thickness difference between the 2 areas was 4 + 4 microns. The ratio of retinal thickness, in areas with leakage to that of areas without leakage, in untreated patients (1.22 + 0.15) was greater than in treated patients (1.02 + 0.02) (P = 0.04). Conclusion:Retinal thickness was increased in areas with leakage on fluorescein angiography in untreated AMD patients, as compared to areas without leakage in untreated eyes and with leakage in treated eyes. Retinal thickness mapping may be a useful tool for quantitative evaluation and monitoring of retinal thickness changes due to CNV and its treatment.

Keywords: imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • age–related macular degeneration • choroid: neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×